APP and Alzheimer disease: The processing of APP generates Aβ, the abnormal accumulation of which leads to the formation of amyloid plaques and the clinical manifestation of early onset (in the forties) Alzheimer's disease (AD) and progressive cognitive decline among individuals with DS.